 So in original. Probably should be “subparagraph (F),”.

the Administrator may award a renewal grant to a grant recipient under this subparagraph 

 So in original. Probably should be “this paragraph”.

for each fiscal year of the 4-fiscal-year period following the first fiscal year for which the initial additional grant is awarded in an amount not to exceed the following:

Editorial Notes

Amendments

2019—Pub. L. 116–74, § 2(c)(1)(A)(ii)(II), made technical amendment to directory language of Pub. L. 115–271, § 8203(b)(4). See 2018 Amendment notes below.

Pub. L. 116–74, § 2(c)(1)(A)(i)(V), made technical amendment to directory language of Pub. L. 115–271, § 8203(a)(3)(A). See 2018 Amendment note below.

Subsec. (b)(1)(A)(iii). Pub. L. 116–74, § 2(c)(1)(A)(ii)(II), (III), (3), amended directory language of Pub. L. 115–271, § 8203(b)(4)(B). See 2018 Amendment note below.

Subsec. (b)(3)(D). Pub. L. 116–74, § 2(c)(1)(A)(ii)(II), (III), (iii), amended directory language of Pub. L. 115–271, § 8203(b)(4)(B). See 2018 Amendment note below.

2018—Pub. L. 115–271, § 8203(b)(4)(A), as amended by Pub. L. 116–74, § 2(c)(1)(A)(ii)(II), substituted “substance use and misuse” for “substance abuse” wherever appearing.

Pub. L. 115–271, § 8203(a)(3)(A), formerly § 8203(a)(4)(A), as renumbered and amended by Pub. L. 116–74, § 2(c)(1)(A)(i)(IV), (V), amended directory language of Pub. L. 109–469, §§ 802(a), 803, 804. See 2006 Amendment notes below.

Subsec. (b)(1)(A)(iii). Pub. L. 115–271, § 8203(b)(4)(B), which originally directed striking cl. (iii) and inserting a new cl. (iii), was subsequently amended by Pub. L. 116–74, § 2(c)(1)(A)(ii)(II), (III), so that it no longer amended cl. (iii) but amended subsec. (b)(3)(D) instead. In addition, Pub. L. 116–74, § 2(c)(3), restored the prior cl. (iii) as if the amendment made by Pub. L. 115–271, § 8203(b)(4), had never been enacted. See subsec. (b)(3)(D) Amendment note below.

Subsec. (b)(3)(D). Pub. L. 115–271, § 8203(b)(4)(B), as amended by Pub. L. 116–74, § 2(c)(1)(A)(ii)(II), (III), (iii), amended subpar. (D) generally. Prior to amendment, text read as follows: “Subject to subparagraph (F), the Administrator may award a renewal grant to a grant recipient under this paragraph for each of the fiscal years of the 4-fiscal-year period following the fiscal year for which the initial additional grant under subparagraph (A) is awarded in an amount not to exceed amounts as follows:

“(i) For the first and second fiscal years of that 4-fiscal-year period, the amount equal to 80 percent of the non-Federal funds, including in-kind contributions, raised by the coalition for the applicable fiscal year.

“(ii) For the third and fourth fiscal years of that 4-fiscal-year period, the amount equal to 67 percent of the non-Federal funds, including in-kind contributions, raised by the coalition for the applicable fiscal year.”

2006—Subsec. (a)(7). Pub. L. 109–469, § 804, as amended by Pub. L. 115–271, § 8203(a)(3)(A), added par. (7).

Subsec. (b)(1)(A)(iv), (2)(C)(i), (3)(F). Pub. L. 109–469, § 803, as amended by Pub. L. 115–271, § 8203(a)(3)(A), substituted “$125,000” for “$100,000”.

Subsec. (b)(4). Pub. L. 109–469, § 802(a), as amended by Pub. L. 115–271, § 8203(a)(3)(A), added par. (4).

2001—Subsec. (b)(3). Pub. L. 107–82, § 1(d), added par. (3).

Subsec. (c). Pub. L. 107–82, § 1(g), added subsec. (c).

Subsec. (d). Pub. L. 107–82, § 1(h), added subsec. (d).

Statutory Notes and Related Subsidiaries

Effective Date of 2019 Amendment

Amendment by Pub. L. 116–74 effective as if included in the enactment of subtitle K of title VIII of Pub. L. 115–271, see section 2(c)(2) of Pub. L. 116–74, set out as a note under section 1522 of this title.

Effective Date of 2018 Amendment

Amendment by section 8203(a)(3)(A) of Pub. L. 115–271 effective as if enacted as part of Pub. L. 109–469, see section 8203(a)(3)(B) of Pub. L. 115–271, set out as a note under section 1524 of this title.

Waiver of Federal Fund Limitation for the Drug-Free Communities Support Program

Pub. L. 117–103, div. P, title I, § 161, Mar. 15, 2022, 136 Stat. 801, provided that:

“(a)

In General.—

Subject to subsection (b), if the Administrator of the Drug-Free Communities Support Program determines that, as a result of the public health emergency declared pursuant to section 319 of the Public Health Service Act (42 U.S.C. 247d) with respect to COVID–19, an eligible coalition is unable to raise the amount of non-Federal funds, including in-kind contributions, agreed to be raised by the coalition for fiscal year 2020, 2021, or 2022 under an agreement entered into with the Administrator pursuant to paragraph (1)(A) or (3) of section 1032(b) of the Anti-Drug Abuse Act of 1988 (21 U.S.C. 1532(b)), the Administrator may, notwithstanding such paragraphs, provide to the eligible coalition the grant or renewal grant, as applicable, for that fiscal year only in an amount—

“(1)

with respect to an initial grant or renewal grant described under paragraph (1)(A) or (3)(A) of such section, that exceeds the amount of non-Federal funds raised by the eligible coalition, including in-kind contributions, for that fiscal year;

“(2)

with respect to a renewal grant described under paragraph (3)(D)(i) of such section, that exceeds 125 percent of the amount of non-Federal funds raised by the eligible coalition, including in-kind contributions, for that fiscal year; and

“(3)

with respect to a renewal grant described under paragraph (3)(D)(ii) of such section, that exceeds 150 percent of the amount of non-Federal funds raised by the eligible coalition, including in-kind contributions, for that fiscal year.

“(b)

Limitation.—

The Administrator may not provide a grant or renewal grant to an eligible coalition in an amount exceeding the amount of funds initially agreed to be provided by the Administrator under the applicable agreement.”

Report to Congress

Pub. L. 109–469, title VIII, § 802(b), Dec. 29, 2006, 120 Stat. 3535, as amended by Pub. L. 115–271, title VIII, § 8203(a)(3)(A), formerly § 8203(a)(4)(A), Oct. 24, 2018, 132 Stat. 4111, as renumbered by Pub. L. 116–74, § 2(c)(1)(A)(i)(IV), Nov. 27, 2019, 133 Stat. 1157; Pub. L. 116–74, § 2(c)(1)(A)(i)(V), Nov. 27, 2019, 133 Stat. 1157, provided that: “Not later than 60 days after the date of enactment of this Act [Dec. 29, 2006], the Director of the Office of National Drug Control Policy shall submit to Congress a report detailing the appeals process required by section 1032(b)(4) of the Anti-Drug Abuse Act of 1988 [21 U.S.C. 1532(b)(4)], as added by subsection (a).”